12:00 AM
May 14, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Immunocore preclinical data

In a mouse xenograft model of melanoma, once-daily 0.1, 0.04 and 0.01 mg/kg IV ImmTAC-gp100 for 4 days significantly inhibited tumor growth at day...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >